Stock market week-in-review for 5 large GI companies — Oct. 16-20

Written by Eric Oliver | October 24, 2017 | Print  |

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Oct. 16 to Oct. 20, 2017.

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $204.51 on Oct. 16
Peaked: $206.75 on Oct. 16
Closed: $188.19 on Oct. 20
Percent change between Oct. 16 and Oct. 20: -7.98 percent

2. Exact Sciences Corp.

Opened: $47.41 on Oct. 16
Peaked: $49.34 on Oct. 20
Closed: $49.15 on Oct. 20
Percent change between Oct. 16 and Oct. 20: 3.67 percent

3. Johnson & Johnson

Opened: $136.90 on Oct. 16
Peaked: $143.57 on Oct. 20
Closed: $142.38 on Oct. 20
Percent change between Oct. 16 and Oct. 20: 4 percent

4. Synergy Pharmaceuticals

Opened: $3.09 on Oct. 16
Peaked: $3.23 on Oct. 16
Closed: $2.81 on Oct. 20
Percent change between Oct. 16 and Oct. 20: -9.06 percent

5. Valeant Pharmaceuticals

Opened: $13.38 on Oct. 16
Peaked: $13.42 on Oct. 16
Closed: $12.16 on Oct. 20
Percent change between Oct. 16 and Oct. 20: -9.11 percent

More articles on gastroenterology: 
GI leader to know: Dr. Kenneth Brown
4 insights on NASH from the physicians fighting it
DIY bowel prep leaves GI physicians concerned — 7 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.